Why the study?
To determine the prevalence of metabolic syndrome in patients presenting with acute coronary syndrome.
Metabolic syndrome is highly prevalent (35.3%) among patients presenting with acute coronary syndrome, highlighting the need for targeted metabolic risk management in this population.
May support MetS screening in ACS; leaves open prognostic value and causal links.
Objective: To determine the prevalence of metabolic syndrome (MetS) in patients of acute coronary syndrome. Methodology: This cross-sectional study was conducted in department of cardiology, CPE institute of cardiology Multan. A total of 150 patients of ACS who were admitted in the hospital from Oct-2018 to March-2019 were included. Patients demographics, reason for admission in hospital were noted. Waist circumference, body mass index (BMI), serum lipid profile, and fasting blood sugar was measured in all patients. Results: Metabolic syndrome (MetS) was diagnosed in 53 (35.3%). Frequency of heart failure was lower in Non-MetS group; 17 (17.5%) versus 15 (28.3%) in MetS group (p-value 0.12). STEMI was 10 (18.8%) in MetS group whereas it was 28 (28.8%) in Non-MetS group (p-value 0.18). Arrhythmias occurred in 5 (9.4%) in MetS group; as compared to 5 (5.15%) in Non-MetS group (p-value 0.32). Conclusion: The prevalence of MetS in present study was 35.3% and these patients were mostly female and obese. These were more likely admitted because of heart failure and arrhythmias.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: